H.R. 679

Title:  To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Sponser: Harshbarger, Diana [Rep.-R-TN-1] (Introduced 01/23/2025)

Latest Action:

Permanent Link:

pdf:

html:

txt: